RecruitingProstate Cancer
Understanding of Genetics by Men at Risk for Prostate Cancer
Eligible age
40–95 yrs
Accepts
Men
Locations
3 states
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
With this greater certainty regarding prognosis, men with localized prostate cancer are now equipped with make better treatment planning decisions. This study is designed to investigate the understanding of prognostic genetic technology in African American and rural White men at risk for localized prostate cancer.
Sponsor: Mayo Clinic
You may qualify if…
- ✓ African-American or White men
- ✓ Living in a rural or urban areas
- ✓ Age 40 to 95 years old
- ✓ Able and willing to provide informed consent
- ✓ English-speaking
- ✓ Willing to participate in the study.
- ✓ This study will use the United States Department of Agriculture Office of Rural Development's definition of rural, which is as a city or town that has a population less than 50,000 inhabitants to define rural.
- ✓ This study will use the United States Census Bureau's definition of urban, which is a city or town that has a population greater than 50,000 inhabitants to define urban.
You may not qualify if…
- ✕ Women will be excluded from participating in this study. However, women will be recruited to serve on an advisory panel to review the video-based educational tool for the comprehension of genomic terminology for prognostic genetic testing in patients with localized prostate cancer.
Where it's recruiting
Source: ClinicalTrials.gov · NCT04550845 · last updated 2025-11-06